LEONARD JOHN M — SEC insider filings
SEC reporting owner CIK 1563584. 37 insider filings on record with FilingPulse; latest filed 2026-11-03.
Transaction summary — filings shown
Covers all 37 filings on record, filed 2020-08-07 to 2026-11-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 57 legs across 22 filings — 823,534 shares, $54,656,230 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 88.
- Largest priced transaction: sale of 44,735 shares @ $170.00 ($7,604,950) in Intellia Therapeutics, Inc., filed 2021-09-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Intellia Therapeutics, Inc. (NTLA) | President and CEO, Director | 31 | — | 57 legs · 823,534 sh · $54,656,230 | 82 |
| IQVIA HOLDINGS INC. (IQV) | Director | 6 | — | — | 6 |
Insider filings — LEONARD JOHN M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-03 | 4 | Intellia Therapeutics, Inc. (NTLA) | Sale (S): 9,000 @ $11.99 | EDGAR |
| 2026-08-24 | 4 | Intellia Therapeutics, Inc. (NTLA) | Sale (S): 19,890 @ $12.60 · Sale (S): 2,785 @ $13 | EDGAR |
| 2026-04-27 | 4 | IQVIA HOLDINGS INC. (IQV) | Grant/award (A): 1,571 @ $0 | EDGAR |
| 2026-03-03 | 4 | Intellia Therapeutics, Inc. (NTLA) | Grant/award (A): 156,400 @ $0 · Grant/award (A): 225,400 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Intellia Therapeutics, Inc. (NTLA) | Sale (S): 34,146 @ $9.21 | EDGAR |
| 2025-12-12 | 4 | Intellia Therapeutics, Inc. (NTLA) | Option exercise (M): 49,959 @ $6.83 · Sale (S): 49,959 @ $9.49 · Sale (S): 32,832 @ $9.47 · Sale (S): 5,355 @ $9.59 · Option exercise (M): 8,557 @ $6.83 · Option exercise (M): 49,959 (derivative) @ $0 · +1 more | EDGAR |
| 2025-04-25 | 4 | IQVIA HOLDINGS INC. (IQV) | Grant/award (A): 1,592 @ $0 | EDGAR |
| 2025-03-04 | 4 | Intellia Therapeutics, Inc. (NTLA) | Grant/award (A): 136,000 @ $0 · Grant/award (A): 196,000 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | Intellia Therapeutics, Inc. (NTLA) | Sale (S): 26,807 @ $12.18 | EDGAR |
| 2025-01-03 | 4 | Intellia Therapeutics, Inc. (NTLA) | Option exercise (M): 7,850 · Option exercise (M): 7,850 (derivative) @ $0 | EDGAR |
| 2024-05-09 | 4 | IQVIA HOLDINGS INC. (IQV) | Grant/award (A): 1,047 @ $0 | EDGAR |
| 2024-03-05 | 4 | Intellia Therapeutics, Inc. (NTLA) | Grant/award (A): 113,586 @ $0 · Grant/award (A): 163,929 (derivative) @ $0 | EDGAR |
| 2024-01-05 | 4 | Intellia Therapeutics, Inc. (NTLA) | Sale (S): 19,223 @ $29.46 | EDGAR |
| 2024-01-03 | 4 | Intellia Therapeutics, Inc. (NTLA) | Option exercise (M): 7,848 · Option exercise (M): 7,848 (derivative) @ $0 | EDGAR |
| 2023-05-12 | 4 | IQVIA HOLDINGS INC. (IQV) | Grant/award (A): 1,063 @ $0 | EDGAR |
| 2023-03-03 | 4 | Intellia Therapeutics, Inc. (NTLA) | Grant/award (A): 91,036 @ $0 · Grant/award (A): 128,631 (derivative) @ $0 | EDGAR |
| 2023-01-06 | 4 | Intellia Therapeutics, Inc. (NTLA) | Sale (S): 6,673 @ $37.21 | EDGAR |
| 2023-01-04 | 4 | Intellia Therapeutics, Inc. (NTLA) | Option exercise (M): 7,848 · Option exercise (M): 7,848 (derivative) @ $0 | EDGAR |
| 2022-05-13 | 4 | IQVIA HOLDINGS INC. (IQV) | Grant/award (A): 995 @ $0 | EDGAR |
| 2022-03-04 | 4 | Intellia Therapeutics, Inc. (NTLA) | Option exercise (M): 7,848 · Sale (S): 2,493 @ $112.25 · Grant/award (A): 40,990 @ $0 · Option exercise (M): 7,848 (derivative) @ $0 · Grant/award (A): 59,941 (derivative) @ $0 | EDGAR |
| 2021-09-01 | 4 | Intellia Therapeutics, Inc. (NTLA) | Option exercise (M): 11,637 @ $13.40 · Option exercise (M): 27,167 @ $14.58 · Sale (S): 2,055 @ $152.81 · Sale (S): 2,334 @ $153.66 · Sale (S): 7,428 @ $154.98 · Sale (S): 15,567 @ $155.70 · +15 more | EDGAR |
| 2021-08-25 | 4 | Intellia Therapeutics, Inc. (NTLA) | Option exercise (M): 27,139 @ $13.40 · Sale (S): 18,874 @ $151.54 · Sale (S): 8,165 @ $153.08 · Sale (S): 100 @ $153.52 · Option exercise (M): 27,139 (derivative) @ $0 | EDGAR |
| 2021-08-20 | 4 | Intellia Therapeutics, Inc. (NTLA) | Option exercise (M): 22,682 @ $13.40 · Sale (S): 9,726 @ $150.46 · Sale (S): 6,993 @ $151.56 · Sale (S): 5,963 @ $152.30 · Option exercise (M): 22,682 (derivative) @ $0 | EDGAR |
| 2021-04-19 | 4 | IQVIA HOLDINGS INC. (IQV) | Grant/award (A): 934 @ $0 | EDGAR |
| 2021-04-15 | 4 | Intellia Therapeutics, Inc. (NTLA) | Option exercise (M): 10,000 @ $6.83 · Option exercise (M): 15,937 @ $13.88 · Option exercise (M): 10,000 (derivative) @ $0 · Option exercise (M): 15,937 (derivative) @ $0 | EDGAR |
| 2021-04-02 | 4 | Intellia Therapeutics, Inc. (NTLA) | Option exercise (M): 45,000 @ $14.58 · Sale (S): 24,314 @ $84 · Option exercise (M): 26,041 @ $13.40 · Sale (S): 13,895 @ $83 · Option exercise (M): 45,000 (derivative) @ $0 · Option exercise (M): 26,041 (derivative) @ $0 | EDGAR |
| 2021-03-05 | 4 | Intellia Therapeutics, Inc. (NTLA) | Grant/award (A): 188,363 (derivative) @ $0 · Grant/award (A): 31,394 (derivative) @ $0 | EDGAR |
| 2021-02-09 | 4 | Intellia Therapeutics, Inc. (NTLA) | Option exercise (M): 40,000 @ $13.40 · Sale (S): 8,043 @ $67.18 · Sale (S): 14,018 @ $67.86 · Sale (S): 881 @ $68.78 · Option exercise (M): 56,718 @ $6.83 · Sale (S): 28,043 @ $75 · +2 more | EDGAR |
| 2021-02-03 | 4 | Intellia Therapeutics, Inc. (NTLA) | Option exercise (M): 100,000 @ $6.83 · Sale (S): 16,750 @ $63.32 · Sale (S): 26,058 @ $64.13 · Sale (S): 8,827 @ $65 · Option exercise (M): 10,000 @ $13.88 · Sale (S): 1,709 @ $63.24 · +20 more | EDGAR |
| 2021-01-05 | 4 | Intellia Therapeutics, Inc. (NTLA) | Option exercise (M): 14,375 @ $0 · Sale (S): 6,239 @ $55.86 · Grant/award (A): 28,750 (derivative) @ $0 · Grant/award (A): 14,375 (derivative) @ $0 · Option exercise (M): 14,375 (derivative) @ $0 | EDGAR |
| 2020-11-27 | 4 | Intellia Therapeutics, Inc. (NTLA) | Option exercise (M): 15,000 @ $18.30 · Sale (S): 15,000 @ $38 · Option exercise (M): 20,000 @ $14.58 · Sale (S): 20,000 @ $39 · Option exercise (M): 15,000 (derivative) @ $0 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2020-11-25 | 4 | Intellia Therapeutics, Inc. (NTLA) | Option exercise (M): 50,000 @ $6.83 · Sale (S): 50,000 @ $36 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2020-11-18 | 4 | Intellia Therapeutics, Inc. (NTLA) | Option exercise (M): 20,000 @ $14.58 · Sale (S): 20,000 @ $34 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2020-11-06 | 4 | Intellia Therapeutics, Inc. (NTLA) | Option exercise (M): 50,000 @ $6.83 · Sale (S): 50,000 @ $26 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2020-10-09 | 4 | Intellia Therapeutics, Inc. (NTLA) | Option exercise (M): 5,000 @ $6.83 · Sale (S): 5,000 @ $21.83 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2020-09-03 | 4 | Intellia Therapeutics, Inc. (NTLA) | Option exercise (M): 5,000 @ $6.83 · Sale (S): 5,000 @ $21.83 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2020-08-07 | 4 | Intellia Therapeutics, Inc. (NTLA) | Option exercise (M): 5,000 @ $6.83 · Sale (S): 5,000 @ $21.83 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1563584 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs